Nautilus Biotechnology, Inc. — Form D
Nautilus Biotechnology, Inc. of San Carlos, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-30. The offering totals $27.2M, of which $27.2M was reported sold. Industry: Other.
Offering
- Filed: 2018-05-30
- Form: D
- Accession: 0001741638-18-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $27.2M
- Amount sold: $27.2M
- Remaining: $23
- Investors: 11
- Date of first sale: 2018-05-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-313525
Issuer
- Name: Nautilus Biotechnology, Inc.
- CIK: 0001741638
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 201 Industrial Rd, STE 310, San Carlos, CA, 94070
- Phone: (206) 333-2001
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Matthew Posard | Director | Waltham, MA |
| Stuart Nagae | Director | Seattle, WA |
| Vijay Pande | Director | Richmond, CA |
| Farzad Nazem | Director | Seattle, WA |
| Sujal Patel | Director | Seattle, WA |
| Sujal Patel | Executive Officer | Seattle, WA |
| Parag Mallick | Director | Seattle, WA |
Other filings by this issuer (2)
More